Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Icagen Inc.

Division of XRpro Sciences Inc.
www.icagen.com

Latest From Icagen Inc.

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

Following last December’s partnership in CNS with Autifony, BI undertakes a screening collaboration with Domain. Leo maintains its busy deal-making pace, partnering in dermatology with Evotec.

Deals Business Strategies

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

Public Company Edition: Strategies diverge in obesity as Vivus restructures debt and raises cash for a new deal and new focus, after Orexigen nears a sale of the company via bankruptcy court. Also, Clovis leads recent offerings, while layoffs are on the table at Catabasis.

Financing Business Strategies

Execs On The Move, September 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

People In The News: EFPIA Seeks New Leader, Medicines Australia Finds One

EFPIA's Richard Bergström is moving on; Medicines Australia brings in UK-based lobbyist Milton Catelin as its CEO; Friends of Cancer Research promotes Jeff Allen to CEO, plus more biopharma personnel changes.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • ICAgen Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • XRpro Sciences Inc.
  • Senior Management
  • Richie Cunningham, CEO
    Mark Korb, PhD, CFO
    Douglas Krafte, PhD, CSO
  • Contact Info
  • Icagen Inc.
    Phone: (919) 941-5206
    4222 Emperor Blvd.
    Ste. 350
    Durham, NC 27703
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register